Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Chris Boshoff, Pfizer's chief scientific officer, said in the release
Practical access strategies For patients in markets where both peptides are available, tirzepatide is the practical choice due to established availability, known dosing protocols, extensive clinical experience, and insurance coverage pathways
In the SURMOUNT-1 study, a phase 3 clinical trial in obese patients, randomized participants in a 1:1:1:1 ratio to tirzepatide (5, 10, 15 mg) or placebo over 72 weeks, significant weight reductions were observed at 72 weeks: 15.0% for 5 mg, 19.5% for 10 mg, 20.9% for 15 mg, compared to 3.1% for placebo [18]
Repeat until clear
Patients should consult a licensed healthcare provider before starting or changing any therapy
GLP-1 medications like Ozempic, Mounjaro, and Wegovy have transformed weight loss treatment, helping millions achieve results that were previously impossible through diet and exercise alone
US$ 20.01
US$ 24.25
US$ 21.70
US$ 23.76
US$ 27.14
